Clinical Trial Update: Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating high-dose conformational radiotherapy and hyperselective transarterial chemoembolization for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Nantes University Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED